-
ACLA Statement on Medicare Reimbursement Rate For Serologic Testing
WASHINGTON, D.C. – Following the release by the Centers for Medicare and Medicaid Services (CMS) of a reimbursement rate of $42.13 for the most commonly-performed ... Read More -
ACLA Statement on HEROES Act
WASHINGTON, D.C. — Following the introduction of the ‘‘Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act” ACLA President Julie Khani issued the following statement: “ACLA is currently ... Read More -
ACLA Statement on Expanding Access to Testing
WASHINGTON, D.C. — Following the Trump Administration’s announcements today on expanding access to testing, ACLA President Julie Khani released the following statement: “After scaling up to meet an ... Read More -
ACLA Statement on Support Necessary For Laboratories
WASHINGTON, D.C. — Following ongoing developments related to COVID-19 testing and response, ACLA President Julie Khani issued the following statement: “Labs are not scaling back. We’re ramping ... Read More -
ACLA Statement on FDA’s Revised Policy for Serologic Tests
WASHINGTON, D.C. – Following the revised policy on serologic testing announced today by the Food and Drug Administration, ACLA President Julie Khani issued the following ... Read More -
ACLA Statement on White House Meeting
WASHINGTON, D.C. – Following today’s meeting at the White House, ACLA President Julie Khani issued the following statement: “ACLA appreciated the opportunity to meet today ... Read More -
ACLA Statement on the Paycheck Protection Program and Health Care Enhancement Act
WASHINGTON, D.C. — Following Senate passage of the Paycheck Protection Program and Health Care Enhancement Act, ACLA President Julie Khani released the following statement: ACLA ... Read More -
Clinical Labs Support Congressional Funding To Ensure Robust Testing Infrastructure
Federal Funding Is Needed To Ensure Laboratories Can Scale High Throughput Testing For COVID-19 Washington, D.C. – The American Clinical Laboratory Association is encouraged by ... Read More -
Dave King joins ACLA as Special Advisor
WASHINGTON, D.C. — The American Clinical Laboratory Association (ACLA) today announced Dave King, former CEO of Laboratory Corporation of America Holdings (LabCorp), will join ACLA as ... Read More -
As Nation Recognizes Laboratory Professionals Week, ACLA Highlights Extraordinary Efforts of “The Laboratory People”
Association announces plans to highlight members’ efforts during Laboratory Professionals Week (April 19 – 25) WASHINGTON, D.C. — Today, the American Clinical Laboratory Association (ACLA) ... Read More
